NYSE:CNC - Centene Stock Price, Price Target & More

$110.95 -0.42 (-0.38 %)
(As of 04/20/2018 12:01 PM ET)
Previous Close$111.37
Today's Range$110.30 - $111.96
52-Week Range$70.58 - $113.88
Volume301,231 shs
Average Volume1.38 million shs
Market Capitalization$19.67 billion
P/E Ratio22.14
Dividend YieldN/A
Beta0.75

About Centene (NYSE:CNC)

Centene logoCentene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

Receive CNC News and Ratings via Email

Sign-up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:CNC
CUSIP15135B10
Phone314-725-4477

Debt

Debt-to-Equity Ratio0.68%
Current Ratio0.93%
Quick Ratio0.93%

Price-To-Earnings

Trailing P/E Ratio22.14
Forward P/E Ratio15.41
P/E Growth1.07

Sales & Book Value

Annual Sales$48.38 billion
Price / Sales0.40
Cash Flow$7.1627 per share
Price / Cash15.49
Book Value$39.78 per share
Price / Book2.79

Profitability

EPS (Most Recent Fiscal Year)$5.03
Net Income$828 million
Net Margins1.71%
Return on Equity13.68%
Return on Assets4.08%

Miscellaneous

Employees33,700
Outstanding Shares175,270,000

How to Become a New Pot Stock Millionaire

Centene (NYSE:CNC) Frequently Asked Questions

What is Centene's stock symbol?

Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."

How were Centene's earnings last quarter?

Centene Co. (NYSE:CNC) announced its quarterly earnings data on Tuesday, February, 6th. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. The company earned $12.81 billion during the quarter, compared to analysts' expectations of $12.25 billion. Centene had a net margin of 1.71% and a return on equity of 13.68%. Centene's revenue was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.19 EPS. View Centene's Earnings History.

When is Centene's next earnings date?

Centene is scheduled to release their next quarterly earnings announcement on Tuesday, April, 24th 2018. View Earnings Estimates for Centene.

What guidance has Centene issued on next quarter's earnings?

Centene updated its FY18 earnings guidance on Tuesday, February, 6th. The company provided earnings per share (EPS) guidance of $6.95-7.35 for the period, compared to the Thomson Reuters consensus estimate of $5.76. The company issued revenue guidance of $60.6-61.4 billion, compared to the consensus revenue estimate of $60.19 billion.

What price target have analysts set for CNC?

18 brokers have issued twelve-month price objectives for Centene's shares. Their predictions range from $75.00 to $135.00. On average, they anticipate Centene's share price to reach $109.8824 in the next twelve months. View Analyst Ratings for Centene.

What are Wall Street analysts saying about Centene stock?

Here are some recent quotes from research analysts about Centene stock:
  • 1. According to Zacks Investment Research, "In a year's time, Centene's shares have outperformed the industry. The company’s strong and consistent performance is likely to have generated confidence among investors. It has seen substantial inorganic growth in the last five years. The acquisition of Health Net in 2016 bolstered the company’s growth, expansion as well as its asset base. Its solid financial position also provides a major boost to its capital deployment initiatives. The company’s strong Managed care segment also contributes to its strong results. The guidance raise for 2018 instills shareholders' confidence in the company. Centene has seen the Zacks Consensus Estimate for 2018 earnings being revised upward in the last 60 days. However, rising debt burden hurts the company's profitability. Moreover, increasing expenses also continue to weigh on the margins. The company will release first quarter 2018 results on Apr 24." (4/10/2018)
  • 2. Cantor Fitzgerald analysts commented, "This morning, Centene filed an 8-K which indicates that it will contribute $340 million (over five years) to New York State in conjunction with the Fidelis acquisition." (4/2/2018)

Who are some of Centene's key competitors?

Who are Centene's key executives?

Centene's management team includes the folowing people:
  • Mr. Michael Frederic Neidorff, Chairman & CEO (Age 75)
  • Ms. Cynthia J. Brinkley, Pres & COO (Age 58)
  • Mr. Jeffrey Alan Schwaneke CPA, Exec., CFO & Treasurer (Age 42)
  • Mr. Keith Harvey Williamson, Exec. VP, Gen. Counsel & Corp. Sec. (Age 66)
  • Mr. Jesse N. Hunter, Exec. VP & Chief Strategy Officer (Age 42)

Has Centene been receiving favorable news coverage?

Press coverage about CNC stock has been trending somewhat positive recently, according to Accern. The research group rates the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Centene earned a coverage optimism score of 0.01 on Accern's scale. They also gave news headlines about the company an impact score of 44.95 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of Centene?

Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Centene's stock price today?

One share of CNC stock can currently be purchased for approximately $110.62.

How big of a company is Centene?

Centene has a market capitalization of $19.67 billion and generates $48.38 billion in revenue each year. The company earns $828 million in net income (profit) each year or $5.03 on an earnings per share basis. Centene employs 33,700 workers across the globe.

How can I contact Centene?

Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]


MarketBeat Community Rating for Centene (CNC)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  706 (Vote Outperform)
Underperform Votes:  448 (Vote Underperform)
Total Votes:  1,154
MarketBeat's community ratings are surveys of what our community members think about Centene and other stocks. Vote "Outperform" if you believe CNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Centene (NYSE:CNC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
18 Wall Street analysts have issued ratings and price targets for Centene in the last 12 months. Their average twelve-month price target is $109.8824, suggesting that the stock has a possible downside of 0.96%. The high price target for CNC is $135.00 and the low price target for CNC is $75.00. There are currently 3 hold ratings and 15 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.832.742.68
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $109.8824$109.8824$103.50$94.9444
Price Target Upside: 0.96% downside6.59% upside0.89% upside4.43% upside

Centene (NYSE:CNC) Consensus Price Target History

Price Target History for Centene (NYSE:CNC)

Centene (NYSE:CNC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/2/2018Cantor FitzgeraldReiterated RatingBuy$125.00LowView Rating Details
3/26/2018BMO Capital MarketsReiterated RatingBuyLowView Rating Details
2/13/2018Leerink SwannReiterated RatingMarket Perform -> Market Perform$100.00 -> $90.00LowView Rating Details
2/7/2018Credit Suisse GroupBoost Price TargetNeutral -> Neutral$110.00 -> $112.00LowView Rating Details
2/7/2018Morgan StanleyBoost Price TargetOverweight -> Overweight$118.00 -> $126.00MediumView Rating Details
2/7/2018CitigroupReiterated RatingOutperform$122.00 -> $130.00LowView Rating Details
1/3/2018Goldman SachsInitiated CoverageBuy$135.00MediumView Rating Details
12/20/2017OppenheimerBoost Price TargetOutperform$111.00 -> $122.00LowView Rating Details
12/18/2017Jefferies GroupBoost Price TargetBuy -> Buy$112.00 -> $115.00MediumView Rating Details
12/18/2017Piper JaffrayReiterated RatingBuy$134.00HighView Rating Details
10/24/2017CowenReiterated RatingBuy$115.00N/AView Rating Details
9/14/2017Deutsche BankReiterated RatingBuy$95.00 -> $111.00LowView Rating Details
7/26/2017UBSReiterated RatingBuy$88.00 -> $95.00LowView Rating Details
7/14/2017Bank of AmericaBoost Price TargetBuy$93.00 -> $95.00LowView Rating Details
7/11/2017Sanford C. BernsteinReiterated RatingOutperformMediumView Rating Details
5/22/2017JPMorgan ChaseDowngradeOverweight -> Neutral$75.00MediumView Rating Details
4/26/2017Evercore ISIBoost Price TargetOutperform$80.00 -> $83.00HighView Rating Details
4/26/2017Stifel NicolausBoost Price TargetBuy$80.00 -> $85.00HighView Rating Details
2/8/2017BarclaysBoost Price TargetOverweight$75.00 -> $79.00N/AView Rating Details
9/7/2016WedbushReiterated RatingOutperform$85.00N/AView Rating Details
9/1/2016FBR & CoReiterated RatingBuyN/AView Rating Details
6/28/2016Wolfe ResearchInitiated CoverageMarket Perform$80.00N/AView Rating Details
6/20/2016Wells FargoReiterated RatingBuyN/AView Rating Details
(Data available from 4/20/2016 forward)

Earnings

Centene (NYSE:CNC) Earnings History and Estimates Chart

Earnings by Quarter for Centene (NYSE:CNC)

Centene (NYSE:CNC) Earnings Estimates

2018 EPS Consensus Estimate: $7.16
2019 EPS Consensus Estimate: $8.21
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$1.90$2.00$1.95
Q2 20183$1.80$1.92$1.88
Q3 20183$1.90$1.95$1.92
Q4 20183$1.38$1.46$1.41
Q1 20191$2.28$2.28$2.28
Q2 20191$2.18$2.18$2.18
Q3 20191$2.14$2.14$2.14
Q4 20191$1.61$1.61$1.61

Centene (NYSE CNC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2018$1.61N/AView Earnings Details
2/6/2018Q4 2017$0.94$0.97$12.2478 billion$12.8060 billionViewListenView Earnings Details
10/24/2017Q3 2017$1.24$1.35$11.7479 billion$11.8980 billionViewN/AView Earnings Details
7/25/2017Q2 2017$1.30$1.59$11.6936 billion$11.9540 billionViewN/AView Earnings Details
4/25/2017Q1 17$1.06$1.12$11.4381 billion$11.7240 billionViewN/AView Earnings Details
2/7/2017Q416$1.11$1.19$10.94 billion$11.91 billionViewN/AView Earnings Details
10/25/2016Q316$1.15$1.11$10.96 million$10.85 billionViewListenView Earnings Details
7/26/2016Q216$1.09$1.29$10.80 billion$10.90 billionViewListenView Earnings Details
4/26/2016Q116$0.74$0.74$7.88 billion$6.95 billionViewListenView Earnings Details
2/9/2016Q415$0.82$0.95$6.14 billion$6.30 billionViewN/AView Earnings Details
10/27/2015Q315$0.78$0.84$5.79 billion$5.82 billionViewListenView Earnings Details
7/28/2015Q215$0.69$0.73$5.54 billion$5.51 billionViewListenView Earnings Details
4/28/2015Q115$0.48$0.52$5.12 billion$5.13 billionViewListenView Earnings Details
2/3/2015Q414$1.70$1.74$4.62 billion$4.42 billionViewListenView Earnings Details
10/28/2014Q314$0.96$1.22$4.23 billion$4.35 billionViewListenView Earnings Details
7/22/2014Q214$0.73$0.79$3.66 billion$4.02 billionViewListenView Earnings Details
4/22/2014Q1$0.44$0.57$3.25 billion$3.35 billionViewListenView Earnings Details
2/4/2014Q413$0.83$0.84$2.93 billion$2.86 billionViewListenView Earnings Details
10/22/2013Q313$0.84$0.87$2.68 billion$2.70 billionViewListenView Earnings Details
7/23/2013Q2 2013$0.62$0.77$2.63 billion$2.73 billionViewListenView Earnings Details
4/23/2013Q1 2013$0.38$0.42$2.46 billion$2.54 billionViewListenView Earnings Details
2/5/2013Q4 2012$0.32$0.17$2.40 billion$2.30 billionViewListenView Earnings Details
10/23/2012$0.48$0.07ViewN/AView Earnings Details
7/24/2012($0.10)($0.16)ViewN/AView Earnings Details
4/24/2012$0.48$0.45ViewN/AView Earnings Details
2/7/2012$0.55$0.57ViewN/AView Earnings Details
10/25/2011$0.53$0.55ViewN/AView Earnings Details
7/26/2011$0.54$0.54ViewN/AView Earnings Details
4/26/2011$0.42$0.46ViewN/AView Earnings Details
2/8/2011$0.48$0.50ViewN/AView Earnings Details
10/26/2010Q3 2010$0.24$0.24ViewN/AView Earnings Details
7/27/2010Q2 2010$0.21$0.23ViewN/AView Earnings Details
4/27/2010Q1 2010$0.19$0.21ViewN/AView Earnings Details
2/9/2010Q4 2009$0.26$0.27ViewN/AView Earnings Details
10/27/2009Q3 2009$0.25$0.26ViewN/AView Earnings Details
7/28/2009Q2 2009$0.23$0.23ViewN/AView Earnings Details
4/28/2009Q1 2009$0.20$0.21ViewN/AView Earnings Details
2/10/2009Q4 2008$0.26$0.26ViewN/AView Earnings Details
10/28/2008Q3 2008$0.23$0.24ViewN/AView Earnings Details
7/22/2008Q2 2008$0.19$0.20ViewN/AView Earnings Details
4/22/2008Q1 2008$0.27$0.29ViewN/AView Earnings Details
2/8/2008Q4 2007$0.24$0.10ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Centene (NYSE:CNC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Centene (NYSE CNC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.00%
Institutional Ownership Percentage: 90.58%
Insider Trading History for Centene (NYSE:CNC)
Institutional Ownership by Quarter for Centene (NYSE:CNC)

Centene (NYSE CNC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/12/2018Christopher D. BowersEVPSell4,800$102.27$490,896.00View SEC Filing  
2/13/2018Stephen WallaceDirectorBuy5,000$0.08$400.00
2/8/2018Robert K. DitmoreDirectorSell8,750$104.13$911,137.50View SEC Filing  
1/30/2018Stephen WallaceDirectorBuy5,000$0.09$450.00
1/8/2018Robert K. DitmoreDirectorSell8,750$104.30$912,625.00View SEC Filing  
1/2/2018Keith H. WilliamsonEVPSell5,000$100.11$500,550.00View SEC Filing  
12/19/2017Jesse N. HunterEVPSell10,000$98.73$987,300.00View SEC Filing  
10/26/2017Robert K. DitmoreDirectorSell4,167$90.42$376,780.14View SEC Filing  
8/1/2017Christopher D. BowersEVPSell4,000$79.43$317,720.00View SEC Filing  
7/27/2017Robert K. DitmoreDirectorSell4,167$82.59$344,152.53View SEC Filing  
7/6/2017Michael F. NeidorffChairmanSell35,000$80.26$2,809,100.00View SEC Filing  
6/12/2017Richard A. GephardtDirectorSell4,350$77.38$336,603.00View SEC Filing  
6/2/2017Mark J. BrooksSVPSell2,161$75.43$163,004.23View SEC Filing  
6/2/2017Robert K. DitmoreDirectorSell3,900$75.43$294,177.00View SEC Filing  
5/1/2017Jesse N. HunterEVPSell5,000$74.40$372,000.00View SEC Filing  
5/1/2017Stephen WallaceDirectorBuy100,000$0.04$4,000.00
4/27/2017Christopher D. BowersEVPSell3,150$72.80$229,320.00View SEC Filing  
4/27/2017Robert K. DitmoreDirectorSell4,167$72.43$301,815.81View SEC Filing  
3/27/2017Keith H. WilliamsonEVPSell6,000$70.03$420,180.00View SEC Filing  
3/13/2017Jeffrey A. SchwanekeCFOSell2,000$68.52$137,040.00View SEC Filing  
2/13/2017Jesse N. HunterEVPSell5,000$69.54$347,700.00View SEC Filing  
12/1/2016Mark J. BrooksSVPSell1,099$58.00$63,742.00View SEC Filing  
11/7/2016Jesse N. HunterEVPSell5,000$65.00$325,000.00View SEC Filing  
10/3/2016Carol GoldmanVPSell10,000$66.36$663,600.00View SEC Filing  
10/3/2016Kenneth Rone BaldwinEVPSell6,000$66.58$399,480.00View SEC Filing  
9/7/2016Robert K. DitmoreDirectorBuy150$67.00$10,050.00View SEC Filing  
7/1/2016Kenneth Rone BaldwinEVPSell6,000$71.00$426,000.00View SEC Filing  
6/29/2016Richard A. GephardtDirectorSell15,910$68.89$1,096,039.90View SEC Filing  
6/24/2016Keith H. WilliamsonEVPSell4,000$70.00$280,000.00View SEC Filing  
6/6/2016Mark J BrooksSVPSell3,914$65.01$254,449.1430,605View SEC Filing  
4/28/2016Jesse N HunterEVPSell10,000$65.17$651,700.00216,329View SEC Filing  
4/1/2016Kenneth Rone BaldwinEVPSell6,000$60.87$365,220.00123,494View SEC Filing  
3/23/2016Carol GoldmanVPSell15,000$62.96$944,400.0078,500View SEC Filing  
1/4/2016Kenneth Rone BaldwinEVPSell6,000$64.68$388,080.00131,770View SEC Filing  
12/22/2015Carol GoldmanVPSell25,000$65.19$1,629,750.0097,448View SEC Filing  
12/22/2015Jeffrey A SchwanekeCAOSell2,000$65.09$130,180.0082,574View SEC Filing  
10/29/2015Carol GoldmanVPSell5,000$60.88$304,400.00103,614View SEC Filing  
7/1/2015Carol GoldmanVPSell5,000$81.20$406,000.00View SEC Filing  
6/22/2015Keith H WilliamsonEVPSell7,000$80.87$566,090.00View SEC Filing  
6/18/2015William N ScheffelCFOSell25,290$79.14$2,001,450.60View SEC Filing  
5/4/2015Donald G ImholzEVPSell5,000$65.08$325,400.00View SEC Filing  
4/30/2015Carol GoldmanVPSell15,998$63.48$1,015,553.04View SEC Filing  
4/30/2015Donald G ImholzEVPSell5,000$63.72$318,600.00View SEC Filing  
4/30/2015Robert K DitmoreDirectorSell15,000$63.83$957,450.00View SEC Filing  
4/6/2015Michael F NeidorffCEOSell10,000$70.43$704,300.00View SEC Filing  
4/1/2015Jesse N HunterEVPSell5,000$69.66$348,300.00View SEC Filing  
3/19/2015Keith H WilliamsonEVPSell5,000$70.18$350,900.00View SEC Filing  
3/13/2015Tommy G ThompsonDirectorSell16,000$65.36$1,045,760.00View SEC Filing  
3/9/2015Robert K DitmoreDirectorSell15,000$63.19$947,850.00View SEC Filing  
1/2/2015Carol GoldmanVPSell8,400$104.87$880,908.00View SEC Filing  
1/2/2015Jesse N HunterEVPSell2,500$104.87$262,175.00View SEC Filing  
12/16/2014Jeffrey A SchwanekeCAOSell5,000$101.80$509,000.00View SEC Filing  
10/1/2014Jesse N HunterEVPSell2,500$81.42$203,550.00View SEC Filing  
9/22/2014Carol GoldmanVPSell12,500$81.85$1,023,125.00View SEC Filing  
9/18/2014Donald G ImholzEVPSell5,000$80.10$400,500.00View SEC Filing  
9/15/2014Keith H WilliamsonEVPSell4,000$77.48$309,920.00View SEC Filing  
9/9/2014Jeffrey A SchwanekeCAOSell1,000$79.51$79,510.00View SEC Filing  
9/9/2014Jesse N HunterEVPSell5,000$79.35$396,750.00View SEC Filing  
9/2/2014Donald G ImholzEVPSell5,000$77.32$386,600.00View SEC Filing  
8/28/2014Jeffrey A SchwanekeCAOSell1,000$77.02$77,020.00View SEC Filing  
5/12/2014Jason HarroldEVPSell2,500$70.00$175,000.0045,048View SEC Filing  
4/2/2014Jason HarroldEVPSell5,000$62.19$310,950.0048,382View SEC Filing  
3/31/2014Edmund KrollSVPSell5,000$62.00$310,000.0041,780View SEC Filing  
3/31/2014William ScheffelCFOSell17,895$61.99$1,109,311.0585,528View SEC Filing  
2/6/2014Jesse HunterEVPSell5,000$61.66$308,300.0097,650View SEC Filing  
2/6/2014Michael NeidorffCEOSell10,000$62.00$620,000.001,745,926View SEC Filing  
12/17/2013Orlando AyalaDirectorBuy17,600$56.41$992,816.0029,193View SEC Filing  
7/25/2013Jeffrey A SchwanekeCAOSell3,000$57.40$172,200.00View SEC Filing  
7/25/2013Jesse N HunterEVPSell5,000$57.41$287,050.00View SEC Filing  
6/13/2013Keith H WilliamsonEVPSell5,800$50.25$291,450.00View SEC Filing  
6/7/2013Donald G ImholzEVPSell5,000$50.00$250,000.00View SEC Filing  
6/3/2013Carol GoldmanVPSell10,000$49.28$492,800.00View SEC Filing  
6/3/2013Jesse N HunterEVPSell6,000$48.28$289,680.00View SEC Filing  
5/30/2013Jason M HarroldEVPSell5,000$50.80$254,000.00View SEC Filing  
5/30/2013Jeffrey A SchwanekeCAOSell3,000$50.68$152,040.00View SEC Filing  
5/30/2013William N ScheffelCFOSell22,191$50.80$1,127,302.80View SEC Filing  
5/10/2013Keith H WilliamsonEVPSell3,000$50.00$150,000.00View SEC Filing  
12/4/2012Carol GoldmanVPSell15,000$45.15$677,250.00View SEC Filing  
12/4/2012Keith H WilliamsonEVPSell9,000$45.10$405,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Centene (NYSE CNC) News Headlines

Source:
DateHeadline
Amid a $1.2 billion building boom in Clayton is a 2-block opportunity up for grabsAmid a $1.2 billion building boom in Clayton is a 2-block 'opportunity' up for grabs
www.bizjournals.com - April 19 at 5:13 PM
[$$] New York Acted Fairly in the Fidelis Care Sale[$$] New York Acted Fairly in the Fidelis Care Sale
finance.yahoo.com - April 19 at 5:13 PM
Sanford C. Bernstein Reaffirms "Outperform" Rating for Centene (CNC)Sanford C. Bernstein Reaffirms "Outperform" Rating for Centene (CNC)
www.americanbankingnews.com - April 19 at 3:34 PM
FY2020 Earnings Estimate for Centene Co. (CNC) Issued By Leerink SwannFY2020 Earnings Estimate for Centene Co. (CNC) Issued By Leerink Swann
www.americanbankingnews.com - April 18 at 8:57 AM
Today’s Research Reports on Trending Tickers: CVS Health and CenteneToday’s Research Reports on Trending Tickers: CVS Health and Centene
finance.yahoo.com - April 17 at 9:10 AM
Analysts Set Expectations for Centene Co.s FY2021 Earnings (CNC)Analysts Set Expectations for Centene Co.'s FY2021 Earnings (CNC)
www.americanbankingnews.com - April 17 at 7:05 AM
Centene (CNC) Scheduled to Post Earnings on TuesdayCentene (CNC) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - April 17 at 3:11 AM
Centene Co. (CNC) Expected to Announce Quarterly Sales of $13.17 BillionCentene Co. (CNC) Expected to Announce Quarterly Sales of $13.17 Billion
www.americanbankingnews.com - April 16 at 3:09 AM
Centene (CNC) Receives "Buy" Rating from Piper JaffrayCentene (CNC) Receives "Buy" Rating from Piper Jaffray
www.americanbankingnews.com - April 15 at 7:48 PM
Centene (CNC) Upgraded to Buy by ValuEngineCentene (CNC) Upgraded to Buy by ValuEngine
www.americanbankingnews.com - April 15 at 7:48 PM
Centene (CNC) Upgraded to "Strong-Buy" at Zacks Investment ResearchCentene (CNC) Upgraded to "Strong-Buy" at Zacks Investment Research
www.americanbankingnews.com - April 15 at 5:06 PM
Centene Co. (CNC) Expected to Announce Earnings of $1.93 Per ShareCentene Co. (CNC) Expected to Announce Earnings of $1.93 Per Share
www.americanbankingnews.com - April 14 at 1:22 PM
Why Health Net is pulling out of the Arizona employer health insurance marketWhy Health Net is pulling out of the Arizona employer health insurance market
finance.yahoo.com - April 13 at 9:15 AM
Zacks Investment Research Lowers Centene (CNC) to HoldZacks Investment Research Lowers Centene (CNC) to Hold
www.americanbankingnews.com - April 10 at 2:51 PM
Cuomo Loots A Catholic CharityCuomo Loots A Catholic Charity
www.wsj.com - April 10 at 9:12 AM
Centenes (CNC) Buy Rating Reaffirmed at Cantor FitzgeraldCentene's (CNC) Buy Rating Reaffirmed at Cantor Fitzgerald
www.americanbankingnews.com - April 5 at 7:26 PM
Centene (CNC) Stock Rating Reaffirmed by OppenheimerCentene (CNC) Stock Rating Reaffirmed by Oppenheimer
www.americanbankingnews.com - April 5 at 7:26 PM
Oppenheimer Increases Centene (CNC) Price Target to $111.00Oppenheimer Increases Centene (CNC) Price Target to $111.00
www.americanbankingnews.com - April 5 at 2:15 PM
Centene To Hold 2018 Annual Meeting Following First Quarter Financial Results Conference CallCentene To Hold 2018 Annual Meeting Following First Quarter Financial Results Conference Call
www.prnewswire.com - April 5 at 9:33 AM
Cooper (COO) Buys LifeGlobal to Widen Fertility Device LineCooper (COO) Buys LifeGlobal to Widen Fertility Device Line
finance.yahoo.com - April 4 at 4:39 PM
Here's Why You Should Invest in ABIOMED (ABMD) Right NowHere's Why You Should Invest in ABIOMED (ABMD) Right Now
finance.yahoo.com - April 4 at 4:39 PM
IRCCO Picks Cerner's HealtheIntent for Patients of IllinoisIRCCO Picks Cerner's HealtheIntent for Patients of Illinois
finance.yahoo.com - April 3 at 4:55 PM
Seagate Technology, Cadence Design Systems, NVIDIA, Micron and Centene highlighted as Zacks Bull and Bear of the DaySeagate Technology, Cadence Design Systems, NVIDIA, Micron and Centene highlighted as Zacks Bull and Bear of the Day
finance.yahoo.com - April 3 at 8:52 AM
Centenes (CNC) "Buy" Rating Reaffirmed at Cantor FitzgeraldCentene's (CNC) "Buy" Rating Reaffirmed at Cantor Fitzgerald
www.americanbankingnews.com - April 2 at 11:16 AM
Today’s Research Reports on Trending Tickers: Centene and Alexion PharmaceuticalsToday’s Research Reports on Trending Tickers: Centene and Alexion Pharmaceuticals
finance.yahoo.com - April 2 at 9:50 AM
Centene (CNC) Upgraded at ValuEngineCentene (CNC) Upgraded at ValuEngine
www.americanbankingnews.com - March 31 at 3:20 PM
Centene Corp (CNC) Given Average Recommendation of "Buy" by AnalystsCentene Corp (CNC) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - March 31 at 9:54 AM
Centene to fill ABQ leadership team with local candidatesCentene to fill ABQ leadership team with local candidates
www.bizjournals.com - March 29 at 4:52 PM
The Biggest Movers: Centene Shines; Alliance Data DropsThe Biggest Movers: Centene Shines; Alliance Data Drops
finance.yahoo.com - March 29 at 4:52 PM
Centene Corp (CNC) Expected to Announce Earnings of $1.93 Per ShareCentene Corp (CNC) Expected to Announce Earnings of $1.93 Per Share
www.americanbankingnews.com - March 28 at 3:14 PM
Centenes (CNC) "Buy" Rating Reaffirmed at BMO Capital MarketsCentene's (CNC) "Buy" Rating Reaffirmed at BMO Capital Markets
www.americanbankingnews.com - March 27 at 9:43 AM
See what the IHS Markit Score report has to say about Centene Corp.See what the IHS Markit Score report has to say about Centene Corp.
finance.yahoo.com - March 26 at 9:46 AM
More Angst About Facebook: Global Week AheadMore Angst About Facebook: Global Week Ahead
finance.yahoo.com - March 26 at 9:46 AM
Centene (CNC) Rating Increased to Buy at ValuEngineCentene (CNC) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - March 25 at 7:32 PM
Centene Hasnt Fixed Obamacare Plan Doctor Shortage, Washington State SaysCentene Hasn't Fixed Obamacare Plan Doctor Shortage, Washington State Says
www.bloomberg.com - March 24 at 5:22 PM
Centene Hasn’t Fixed Obamacare Plan Doctor Shortage, Washington State SaysCentene Hasn’t Fixed Obamacare Plan Doctor Shortage, Washington State Says
finance.yahoo.com - March 22 at 5:17 PM
Centene Corporation (NYSE:CNC), Euronet Worldwide, Inc ... - BenzingaCentene Corporation (NYSE:CNC), Euronet Worldwide, Inc ... - Benzinga
www.benzinga.com - March 21 at 9:29 AM
5 Best Momentum Stocks to Buy Using Driehaus Strategy5 Best Momentum Stocks to Buy Using Driehaus Strategy
finance.yahoo.com - March 21 at 9:29 AM
The 6 Most Inexpensive Growth Stocks To Buy NowThe 6 Most Inexpensive Growth Stocks To Buy Now
investorplace.com - March 20 at 5:57 PM
Sacramento receives proposal for possible Centene campusSacramento receives proposal for possible Centene campus
www.bizjournals.com - March 20 at 5:00 PM
Should Value Investors Pick Centene Corporation (CNC) Stock?Should Value Investors Pick Centene Corporation (CNC) Stock?
finance.yahoo.com - March 20 at 5:00 PM
5 Reasons Why Centene is an Attractive Bet for Investors5 Reasons Why Centene is an Attractive Bet for Investors
finance.yahoo.com - March 20 at 5:00 PM
Centene Makes Investment in RxAdvance, Builds PartnershipCentene Makes Investment in RxAdvance, Builds Partnership
www.zacks.com - March 15 at 10:09 AM
Centene (CNC) Makes Initial Investment in RxAdvanceCentene (CNC) Makes Initial Investment in RxAdvance
www.streetinsider.com - March 15 at 10:09 AM
Ex-Apple Chief on new venture, RxAdvanceEx-Apple Chief on new venture, RxAdvance
finance.yahoo.com - March 15 at 10:09 AM
Ex-Apple chief: Centene partnership with pharmacy start-up will drive better care with lower costsEx-Apple chief: Centene partnership with pharmacy start-up will drive better care with lower costs
www.cnbc.com - March 15 at 8:34 AM
Cigna on Raters Radar After Express Scripts Bid, Stock Down - NasdaqCigna on Raters' Radar After Express Scripts Bid, Stock Down - Nasdaq
www.nasdaq.com - March 14 at 4:50 PM
Cigna on Raters' Radar After Express Scripts Bid, Stock DownCigna on Raters' Radar After Express Scripts Bid, Stock Down
finance.yahoo.com - March 14 at 12:00 PM
Insider Selling: Centene Corp (CNC) EVP Sells 4,800 Shares of StockInsider Selling: Centene Corp (CNC) EVP Sells 4,800 Shares of Stock
www.americanbankingnews.com - March 13 at 10:10 PM
Analyst: Why Diplomat Could Be Amazons Ticket Into The Pharma Space - BenzingaAnalyst: Why Diplomat Could Be Amazon's Ticket Into The Pharma Space - Benzinga
www.benzinga.com - March 13 at 5:16 PM

SEC Filings

Centene (NYSE:CNC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Centene (NYSE:CNC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Centene (NYSE CNC) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.